Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Torsten Tonn"'
Publikováno v:
Blood. 130:925-925
Background: The ABO blood group system is unequivocally the most important in clinical transfusion medicine. Furthermore ABO is implicated in the development of a number of human diseases. The ABO antigens are not confined to RBCs but are widely expr
Autor:
Sven Becker, Barbara Uherek, Winfried S. Wels, Hans-Georg Klingemann, Christoph Uherek, Barbara S. Schnierle, Torsten Tonn
Publikováno v:
Blood. 100:1265-1273
The continuously growing natural killer (NK) cell line NK-92 is highly cytotoxic against malignant cells of various origins without affecting normal human cells. Based on this selectivity, the potential of NK-92 cells for adoptive therapy is currentl
Publikováno v:
Blood. 128:1247-1247
More than 100 ABO subgroup-related variations were detected in the coding region of glycosyltransferases, which may be causative for a weak blood group antigen A or B expression. Most variation in expression is explained genetically by mutations that
Publikováno v:
Blood. 126:5428-5428
While adoptive transfer of virus antigen specific T cells has shown to be effective in therapy of resistant recurrent viremia which is frequently associated with the lack of protective immunity following hematopoietic stem cell transplantation, the t
Publikováno v:
Blood. 126:158-158
In clinical transfusion and transplantation medicine, AB0 is the most important blood group system. A and B antigens are synthesized by glycosyltransferases A and B encoded by co-dominantly inherited A and B genes. The 0 phenotype derives from a sing
Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation
Autor:
Cornelia S. Link, Elke Rücker-Braun, Sebastian Tuve, Sarah Matko, Marc Schmitz, Rebekka Wehner, Antje Tunger, Katja Sockel, Stefani Parmentier, Jan Moritz Middeke, Änne Boldt, Johannes Schetelig, Markus Odendahl, Torsten Tonn, Martin Bornhäuser, Falk Heidenreich
Publikováno v:
Blood. 122:5488-5488
Introduction CMV-infection is a serious complication in patients after allogeneic stem cell transplantation (SCT) where immunosuppressive therapy and impaired T cell reconstitution result in a high risk for viral infections. Monitoring of CMV-virus l
Autor:
Stephanie von Harsdorf, Detlef Michel, Torsten Tonn, Erhard Seifried, Mark Ringhoffer, Götz Ulrich Grigoleit, Hartmut Döhner, Marcus Odendahl, Thomas Mertens, Markus Rojewski, Simone Ringhoffer, Anita Schmitt, Michael Schmitt, Hermann Einsele, Martin Marx, Dirk H. Busch, Lothar Germeroth, Markus Wiesneth, Donald Bunjes
Publikováno v:
Blood. 112:1181-1181
Background: Cytomegalovirus (CMV) disease constitutes a serious complication after allogeneic peripheral blood stem cell transplantation (allo-PBSCT). For the clearance of CMV, CD8+ T cells are pivotal. Patients after allo-PBSCT with recurrent CMV re
Autor:
Juergen Loeffler, Kerstin Fick, Goetz Ulrich Grigoleit, Sen Mui Tan, Andreas Opitz, Hermann Einsele, Markus Kapp, Stefan Stevanovic, Torsten Tonn
Publikováno v:
Blood. 110:3231-3231
The Graft-versus-Leukemia (GVL) effect following allogeneic hematopoetic stem cell transplantation (HSCT) is one of the most prominent examples showing the ability of the immune system to eliminate malignant diseases. This effect was a strictly clini
Autor:
Hartmut Döhner, Donald Bunjes, Markus Wiesneth, Markus Rojewski, Stefanie von Harsdorf, Michael Schmitt, Torsten Tonn, Ulrich Grigoleit, Manuel Odendahl, Anita Schmitt, Lothar Germeroth, Clemens Bechter, Junxia Yao, Hermann Einsele, Dirk H. Busch
Publikováno v:
Blood. 110:1964-1964
Cytomegalovirus (CMV) reactivation constitutes a serious complication after allogeneic peripheral blood stem cell transplantation (PBSCT). The frequency of CMVpp65 specific CD8+ T cells is pivotal for the clearance of CMV. CMVpp65 specific CD8+ T cel
Autor:
Michael Paulussen, Dirk Schwabe, Martin Stern, Johannes Rischewski, Ulrike Koehl, Jan Soerensen, Sandrine Meyer-Monard, Peter Bader, Jakob Passweg, Thomas Klingebiel, Alois Gratwohl, Torsten Tonn, André Tichelli
Publikováno v:
Blood. 108:411-411
Allogeneic natural killer cells may exert cytotoxic activity against HLA-nonidentical tumor cells. This effect may be exploited after T-cell depleted haploidentical hematopoetic stem cell transplantation (HSCT) by using donor NK-cell infusions (NK-DL